Literature DB >> 32530542

Age-related difference of the association of cardiovascular risk factors with the cardio-ankle vascular index in the Cardiovascular Prognostic Coupling Study in Japan (the Coupling Registry).

Tomoyuki Kabutoya1, Satoshi Hoshide1,2, Takeshi Fujiwara1,3, Keita Negishi1,2,4, Masafumi Nishizawa5, Mitsuyoshi Yamamoto6, Kayo Yamagiwa7, Akihiro Kawashima8, Tetsuro Yoshida9, Jun Nakazato10, Yoshio Matsui11, Hiromitsu Sekizuka12, Hideyasu Abe13, Yasuhisa Abe13, Yumiko Fujita14, Kei Sato15, Keisuke Narita16, Norihiro Tsuchiya17, Yoshiaki Kubota18, Toshikazu Hashizume19, Kazuomi Kario1,2.   

Abstract

The value of the cardio-ankle vascular index (CAVI) increases with age. All large-scale studies of the CAVI have investigated patients <80 years old. Thus, the clinical characteristics of high CAVI in patients aged 80 or more remain unclear. Therefore, we investigated (1) the CAVI in very elderly patients and (2) the determinants of a high CAVI in high-risk patients, including very elderly patients. The Cardiovascular Prognostic Coupling Study in Japan (Coupling Registry) is a prospective observational study of Japanese outpatients with any cardiovascular risk factors. We enrolled 5109 patients from 30 institutions (average age 68.7 ± 11.4 years, 52.4% males). We investigated the determinants of the CAVI by separating the patients into three groups: 970 middle-aged (<60 years), 3252 elderly (60-79 years), and 887 very elderly (≥80 years) patients. The CAVI values of the males were significantly higher those of the females in all age groups (<60 years: 7.81 ± 1.11 vs. 7.38 ± 0.99, P < .001; 60-79 years: 9.20 ± 1.29 vs. 8.66 ± 1.07, P < .001; ≥80 years: 10.26 ± 1.39 vs. 9.51 ± 1.12, P < .001). In all age groups, the CAVI of the patients with diabetes/glucose tolerance disorder was higher than that of the patients without diabetes/glucose tolerance disorder (<60 years: 7.82 ± 1.22 vs 7.58 ± 1.03, P = .002; 60-79 years: 9.23 ± 1.20 vs 8.78 ± 1.19, P < .001; ≥80 years: 10.04 ± 1.24 vs 9.75 ± 1.32, P = .002). The determinants of the CAVI in these very elderly patients were age, male sex, low BMI, and mean blood pressure. Diabetes/glucose tolerance disorder and glucose were independently associated with the CAVI in the patients aged <60 years and 60-79 years, but not in those aged ≥80 years after adjusting for other covariates.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  cardio-ankle vascular index; cardiovascular event; cardiovascular risk; registry

Mesh:

Year:  2020        PMID: 32530542      PMCID: PMC8029963          DOI: 10.1111/jch.13896

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  30 in total

Review 1.  Noninvasive assessment of arterial stiffness and risk of atherosclerotic events.

Authors:  James J Oliver; David J Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-06       Impact factor: 8.311

2.  THE EFFECT OF BLOOD PRESSURE ALTERATION ON THE PULSE WAVE VELOCITY.

Authors:  E R NYE
Journal:  Br Heart J       Date:  1964-03

3.  Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.

Authors:  Francesco U S Mattace-Raso; Tischa J M van der Cammen; Albert Hofman; Nicole M van Popele; Michiel L Bos; Maarten A D H Schalekamp; Roland Asmar; Robert S Reneman; Arnold P G Hoeks; Monique M B Breteler; Jacqueline C M Witteman
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

4.  Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients.

Authors:  Aleksandras Laucevičius; Ligita Ryliškytė; Jūratė Balsytė; Jolita Badarienė; Roma Puronaitė; Rokas Navickas; Svetlana Solovjova
Journal:  Medicina (Kaunas)       Date:  2015-06-16       Impact factor: 2.430

5.  A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

Authors:  Kohji Shirai; Junji Utino; Kuniaki Otsuka; Masanobu Takata
Journal:  J Atheroscler Thromb       Date:  2006-04       Impact factor: 4.928

6.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Authors:  Kazuaki Shimamoto; Katsuyuki Ando; Toshiro Fujita; Naoyuki Hasebe; Jitsuo Higaki; Masatsugu Horiuchi; Yutaka Imai; Tsutomu Imaizumi; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Hiroshi Itoh; Hiroshi Iwao; Hisashi Kai; Kazuomi Kario; Naoki Kashihara; Yuhei Kawano; Shokei Kim-Mitsuyama; Genjiro Kimura; Katsuhiko Kohara; Issei Komuro; Hiroo Kumagai; Hideo Matsuura; Katsuyuki Miura; Ryuichi Morishita; Mitsuhide Naruse; Koichi Node; Yusuke Ohya; Hiromi Rakugi; Ikuo Saito; Shigeyuki Saitoh; Kazuyuki Shimada; Tatsuo Shimosawa; Hiromichi Suzuki; Kouichi Tamura; Norio Tanahashi; Takuya Tsuchihashi; Makoto Uchiyama; Shinichiro Ueda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2014-04       Impact factor: 3.872

7.  Reference values of cardio-ankle vascular index in a random sample of a white population.

Authors:  Peter Wohlfahrt; Renata Cífková; Narine Movsisyan; Šárka Kunzová; Jiří Lešovský; Martin Homolka; Vladimír Soška; Petr Dobšák; Francisco Lopez-Jimenez; Ondřej Sochor
Journal:  J Hypertens       Date:  2017-11       Impact factor: 4.844

Review 8.  Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives.

Authors:  Kohji Shirai; Noriyuki Hiruta; Mingquiang Song; Takumi Kurosu; Jun Suzuki; Takanobu Tomaru; Yoh Miyashita; Atsuto Saiki; Mao Takahashi; Kenji Suzuki; Masanobu Takata
Journal:  J Atheroscler Thromb       Date:  2011-05-31       Impact factor: 4.928

9.  Arterial Stiffness Predicts Cognitive Decline in Japanese Community-dwelling Elderly Subjects: A One-year Follow-up Study.

Authors:  Taiki Yukutake; Minoru Yamada; Naoto Fukutani; Shu Nishiguchi; Hiroki Kayama; Takanori Tanigawa; Daiki Adachi; Takayuki Hotta; Saori Morino; Yuto Tashiro; Tomoki Aoyama; Hidenori Arai
Journal:  J Atheroscler Thromb       Date:  2014-12-20       Impact factor: 4.928

10.  Age-related difference of the association of cardiovascular risk factors with the cardio-ankle vascular index in the Cardiovascular Prognostic Coupling Study in Japan (the Coupling Registry).

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Takeshi Fujiwara; Keita Negishi; Masafumi Nishizawa; Mitsuyoshi Yamamoto; Kayo Yamagiwa; Akihiro Kawashima; Tetsuro Yoshida; Jun Nakazato; Yoshio Matsui; Hiromitsu Sekizuka; Hideyasu Abe; Yasuhisa Abe; Yumiko Fujita; Kei Sato; Keisuke Narita; Norihiro Tsuchiya; Yoshiaki Kubota; Toshikazu Hashizume; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-06-12       Impact factor: 3.738

View more
  4 in total

1.  Cardio-Ankle Vascular Index and Heart Failure Hospitalization in Patients With Aortic Stenosis Following Transcatheter Aortic Valve Implantation.

Authors:  Mitsuo Sobajima; Teruhiko Imamura; Yohei Ueno; Hiroshi Onoda; Shuhei Tanaka; Ryuichi Ushijima; Nobuyuki Fukuda; Hiroshi Ueno; Koichiro Kinugawa
Journal:  Circ Rep       Date:  2022-01-29

2.  Cardio-ankle vascular index is more closely associated than brachial-ankle pulse wave velocity with arterial damage and risk of cardiovascular disease in patients with diabetes.

Authors:  Taro Saigusa; Kentaro Watanabe; Yurika Hada; Kota Ishii; Wataru Kameda; Shinji Susa; Kenichi Ishizawa; Hisamitsu Ishihara
Journal:  BMC Cardiovasc Disord       Date:  2022-08-09       Impact factor: 2.174

3.  Different age-related impacts of lean and obesity on cardiovascular prognosis in Japanese patients with cardiovascular risks: The J-HOP (Japan Morning Surge-Home Blood Pressure) Study.

Authors:  Shinichi Toriumi; Tomoyuki Kabutoya; Satoshi Hoshide; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-02       Impact factor: 3.738

4.  Age-related difference of the association of cardiovascular risk factors with the cardio-ankle vascular index in the Cardiovascular Prognostic Coupling Study in Japan (the Coupling Registry).

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Takeshi Fujiwara; Keita Negishi; Masafumi Nishizawa; Mitsuyoshi Yamamoto; Kayo Yamagiwa; Akihiro Kawashima; Tetsuro Yoshida; Jun Nakazato; Yoshio Matsui; Hiromitsu Sekizuka; Hideyasu Abe; Yasuhisa Abe; Yumiko Fujita; Kei Sato; Keisuke Narita; Norihiro Tsuchiya; Yoshiaki Kubota; Toshikazu Hashizume; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-06-12       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.